## CHD: Church & Dwight Co., Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG 1.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($82.30)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Can Procter & Gamble's Shift to DTC and Digital Win New Consumers?**
- Source: TradingView â€” Track All Markets | 20251223T180832 | Somewhat-Bullish | Relevance: 73%
- Procter & Gamble (PG) is shifting its strategy to enhance digital engagement and selectively expand direct-to-consumer (DTC) capabilities to connect with consumers and gather first-party data. This move, while not replacing traditional retail, focuses on strengthening brand relationships and influencing purchasing decisions online. The company aims to accelerate innovation, personalize engagement, and maintain relevance with a new generation of consumers, similar to how Church & Dwight and Colgate-Palmolive are leveraging digital and DTC.

**2. Who Owns Colgate-Palmolive? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251222T150839 | Neutral | Relevance: 60%
- This article details the top institutional shareholders of Colgate-Palmolive (NYSE: CL) and recent insider trading activity. It highlights that major institutional investors, particularly passive managers, dominate ownership, while active managers show mixed positions. Insider transactions lean towards minor selling, which doesn't indicate aggressive sentiment but rather a measured approach to current valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $87 | $85 | +2% |
| 2025-12-17 | Jefferies | $102 | $97 | +5% |
| 2025-12-10 | Deutsche Bank | $100 | $102 | -2% |
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | up | Neutral |
| 2025-12-17 | Jefferies | up | Buy |
| 2025-12-10 | Deutsche Bank | main | Buy |
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 18 ($0.04M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 8.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.96 elevated, pricing in significant growth expectations. Forward P/E 22.8x stretched relative to 7% growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.8B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.96 |
| Forward P/E | 22.8 |
| Current P/E | 24.5 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.4% to -1.0% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 54. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.96% (CS: 50) | Neutral |
| RSI_14 | 53.5 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.006x | Above |
| vs SMA200 | 0.911x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $85.42
- **Stop Loss:** $82.30 (3.7% risk)
- **Target:** $88.54 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 192
- **Position Value:** $16,400.64
- **Portfolio %:** 16.40%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*